# Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection

> **NCT02068430** · PHASE1 · COMPLETED · sponsor: **Stephen Trokel** · enrollment: 6 (actual)

## Conditions studied

- Corneal Ulcers

## Interventions

- **DRUG:** Riboflavin 0.1%
- **OTHER:** UV-X™ Illumination System

## Key facts

- **NCT ID:** NCT02068430
- **Lead sponsor:** Stephen Trokel
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-11
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2023-02-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068430, "Safety and Effectiveness of the UV-X System for Corneal Collagen Cross-Linking in Eyes With Refractory Corneal Infection". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT02068430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*